default author photo

FRANCESCO MAURA

Memorial Sloan Kettering Cancer Center

SCHOLARLY PAPERS

1

DOWNLOADS

11

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome with T-Cell Engaging Bispecific Antibodies

Number of pages: 24 Posted: 12 Feb 2026
Issam S. Hamadeh, Maximillian Merz, Andriy Derkach, Lisa Modelevsky, Alexander Lesokhin, Sham Mailankody, Malin Hultcrantz, Carlyn Rose Tan, Hani Hassoun, Urvi Shah, Kylee Maclachlan, Sridevi Rajeeve, Hamza Hashmi, FRANCESCO MAURA, Ross S. Firestone, Alice X. Wang, Anjali Amin, Dhwani Patel, Michael Scordo, Gunjan Shah, Heather J. Landau, Sergio A. Giralt, Saad Usmani and Neha Korde
Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center - Myeloma Service
Downloads 11 (1,534,404)

Abstract:

Loading...

T-cell engaging bispecific antibodies, cytokine release syndrome, tocilizumab, relapsed/refractory multiple myeloma.